Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy

Title
Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOTHERAPY
Volume 34, Issue 6, Pages 490-499
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-06-08
DOI
10.1097/cji.0b013e31821ca76f

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started